D. Rossi

发表

A new class of bispecific antibodies to redirect T cells for cancer immunotherapy

D. Goldenberg, Thomas M. Cardillo, Thomas M Cardillo, 2014, mAbs.

epratuzumab Trogocytosis of multiple B-cell surface markers by CD22 targeting with

D. Wallace, D. Goldenberg, E. Rossi, 2014 .

Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.

D. Wallace, D. Goldenberg, E. Rossi, 2013, Blood.

Redirected T-Cell Killing of Solid Cancers Targeted with an Anti-CD3/Trop-2–Bispecific Antibody Is Enhanced in Combination with Interferon-α

D. Goldenberg, Thomas M. Cardillo, Thomas M Cardillo, 2014, Molecular Cancer Therapeutics.

Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells.

Rongxiu Li, D. Goldenberg, Thomas M. Cardillo, 2017, Cancer research.

Evaluation of a Novel Hexavalent Humanized Anti-IGF-1R Antibody and Its Bivalent Parental IgG in Diverse Cancer Cell Lines

Rongxiu Li, D. Goldenberg, P. Gupta, 2012, PloS one.

Cancer esearch apeutics , Targets , and Chemical Biology ispecific Antibody-IFN α 2 b Immunocytokine Targeting 0 and HLA-DR Is Highly Toxic to Human R phoma and Multiple Myeloma Cells

D. Goldenberg, R. Stein, Chien-Hsing Chang, 2010 .

Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis.

P. Santisteban, Á. Acebrón, D. Rossi, 1999, Biochimie.

Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2–wild-type Triple-Negative Breast Cancer

D. Goldenberg, R. Sharkey, Thomas M Cardillo, 2017, Clinical Cancer Research.

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer

D. Goldenberg, R. Sharkey, Thomas M Cardillo, 2020, Oncotarget.

IMMU-140, a Novel SN-38 Antibody–Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma

D. Goldenberg, S. Govindan, Thomas M Cardillo, 2017, Molecular Cancer Therapeutics.

Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers.

D. Goldenberg, R. Stein, Thomas M Cardillo, 2011, Blood.

A bispecific antibody-IFNalpha2b immunocytokine targeting CD20 and HLA-DR is highly toxic to human lymphoma and multiple myeloma cells.

D. Goldenberg, R. Stein, E. Rossi, 2010, Cancer research.

phoma and Multiple Myeloma Cells

D. Goldenberg, R. Stein, A. Rossi, 2010 .

SAT0122 Reduction of Peripheral Blood G-Ifn and IL-17 Producing T Cells After Therapy with Abatacept for Rheumatoid Arthritis

A. Tincani, P. Airó, L. Imberti, 2013 .

Abstract 4744: CD22-targeting epratuzumab mediates trogocytosis of multiple cell-surface markers on normal, malignant, and lupus B cells.

D. Wallace, D. Goldenberg, E. Rossi, 2013 .

Congenital human thyroglobulin defect due to low expression of the thyroid-specific transcription factor TTF-1.

P. Santisteban, Á. Acebrón, L. Lamas, 1995, The Journal of clinical investigation.